$1.78B
$20,000
0.0% of portfolio
466
Q3 2024
Reduced 90.84%
$4.37B
$878,000
0.0% of portfolio
13,950
Q3 2024
Reduced 4.35%
$994M
$308,000
0.0% of portfolio
14,358
Q3 2024
Reduced 2.48%
$399M
$0
0.0% of portfolio
29
Q3 2024
Reduced 69.79%
$876M
$4,000
0.0% of portfolio
142
Q4 2023
Reduced 26.04%
$1.13B
$24,000
0.0% of portfolio
1,898
Q3 2024
Added 34.8%
$0
$56,000
0.0% of portfolio
8,617
Q3 2024
Reduced 0.21%
$0
$25,000
0.0% of portfolio
7,800
Q4 2023
Added 1.3%
$0
$0
0.0% of portfolio
105
Q3 2024
Reduced 2.78%
$0
$3,000
0.0% of portfolio
782
Q3 2024
Reduced 3.69%
$3.79B
$1.17 Million
0.0% of portfolio
12,831
Q3 2024
Reduced 3.89%
$1.01B
$302,000
0.0% of portfolio
3,637
Q3 2024
Reduced 12.47%
-
$0
0.0% of portfolio
-
Q3 2024
Added 100.0%
Microchip Technology Inc.
-
$0
0.0% of portfolio
-
Q3 2024
Added 150.0%
$3.63B
$716,000
0.0% of portfolio
4,249
Q3 2024
Added 949.14%
$174M
$0
0.0% of portfolio
500
Q3 2023
New
$893M
$59,000
0.0% of portfolio
5,361
Q3 2024
Reduced 0.33%
$1.15B
$513,000
0.0% of portfolio
7,877
Q3 2024
Reduced 2.69%
$597M
$194,000
0.0% of portfolio
8,698
Q3 2024
Added 24.35%
$853M
$13,000
0.0% of portfolio
219
Q3 2024
Reduced 5.6%
$1.92B
$1.07 Million
0.0% of portfolio
43,214
Q3 2024
Reduced 5.26%
Mineralys Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 6.67%
$3.26B
$11,000
0.0% of portfolio
1,061
Q3 2024
Added 10.64%
$1.71B
$22,000
0.0% of portfolio
588
Q3 2024
Added 262.96%
Mirum Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
$919M
$309,000
0.0% of portfolio
24,180
Q3 2024
Added 2,066.67%
$2.46B
$378,000
0.0% of portfolio
58,112
Q3 2024
Added 0.75%
$416M
$2,000
0.0% of portfolio
257
Q3 2024
Reduced 47.12%
$0
$38,000
0.0% of portfolio
2,779
Q3 2024
Reduced 54.06%
$252M
$0
0.0% of portfolio
21
Q3 2024
Reduced 99.67%
$1.59B
$331,000
0.0% of portfolio
4,179
Q3 2024
Reduced 4.02%
$908M
$321,000
0.0% of portfolio
11,134
Q3 2024
Reduced 1.57%
$636M
$7,000
0.0% of portfolio
1,525
Q2 2024
New
$426M
$4,000
0.0% of portfolio
841
Q4 2023
New
$556M
$319,000
0.0% of portfolio
12,157
Q3 2024
Added 72.54%
-
$0
0.0% of portfolio
-
Q3 2024
Added 299.13%
$0
$30,000
0.0% of portfolio
2,230
Q3 2023
New
Morgan Stanley Direct Lendin
-
$0
0.0% of portfolio
-
Q3 2024
New
$0
$115,000
0.0% of portfolio
22,960
Q3 2024
Added 0.1%
$0
$31,000
0.0% of portfolio
4,000
Q3 2023
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 1,306.59%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
$466M
$43,000
0.0% of portfolio
2,331
Q3 2024
Reduced 62.97%
$3.7B
$1.21 Million
0.0% of portfolio
68,330
Q3 2024
Reduced 8.09%
$1.17B
$363,000
0.0% of portfolio
28,547
Q2 2024
Reduced 0.13%
$3.91B
$90,000
0.0% of portfolio
4,192
Q3 2024
Reduced 14.9%
$418M
$188,000
0.0% of portfolio
13,617
Q3 2024
Added 0.59%
$2.62B
$648,000
0.0% of portfolio
6,347
Q3 2024
Reduced 11.03%
$1.31B
$965,000
0.0% of portfolio
35,272
Q3 2024
Reduced 50.55%